drugset / Trial / NCT02743117
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This prospective annual release study is designed to evaluate the safety of 1 new influenza virus vaccine strain to be included in FluMist Quadrivalent for the 2016-2017 influenza season
Timeline
- Start
- 2016-05-02
- Primary completion
- 2016-11-30
- Completion
- 2016-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Monovalent Influenza Vaccine | Vaccine | — | Intranasal |